Direct Meds
One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
- Semaglutide
- $179/mo
- Tirzepatide
- $224/mo
- Coverage
- Not publicly listed
- Brand-name
- Compounded only
Weigh Direct Meds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Direct Meds dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.
Factor breakdown
Each of the six graded dimensions. See the methodology.
Strengths
- Rare oral/sublingual option in addition to injectable
- All-inclusive pricing with no separate membership fee
- Both molecules — semaglutide and tirzepatide
- Intro promotional pricing near $147
Where it loses points
- Compounded only — not FDA-approved
- Pricing is company-stated, not independently live-verified
- Newer and somewhat ambiguous (operates across multiple domains)
- States served are not disclosed
Bottom line — Grade B−
Best for: Patients who specifically want a non-injection option on both molecules under an all-inclusive price, and are comfortable with a newer operator whose pricing they'll want to confirm directly.
Ranked #26 of 30 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.
Compare with other providers
All 30 providers graded on the same six dimensions.
Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
High-disclosure, high-oversight compounded program with the cleanest verification signals.
The widest formulation spread on the board — oral/sublingual routes plus standard injection.
Lowest semaglutide sticker on the board ($93) paired with some brand-name access and LegitScript verification.
An established pharmacy operator with steady mid-market pricing and a broad catalog.
Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.
Sub-$100 semaglutide and $149 tirzepatide — both molecules, verified and nationwide.
A low-entry compounded tirzepatide program (from $149 microdose) that reaches all 50 states and keeps a brand-name Ozempic path open — a rare combination this far up the value tier.
A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.
The cheapest both-molecule pairing on the board ($100/$133) from a LegitScript-verified operator.
Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.
Mid-value both-molecule pricing ($130/$163), verified, and nationwide.
A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
Mid-market pricing offset by brand-name access and LegitScript verification, all 50 states.
Among the lowest compounded-semaglutide pricing, with some brand-name access.
Tight both-molecule spread ($133/$166), verified and nationwide.
Cheap semaglutide ($119) but a steeper tirzepatide step-up ($229); verified, nationwide.
Round mid-market pricing ($149/$199), verified and available nationwide.
Low both-molecule pricing ($117/$159) and verified — but only 36 states.
Among the cheapest both-molecule pairings ($99/$139), nationwide — but not LegitScript-listed.
Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.
Verified and nationwide, but priced in the upper-mid band ($152/$246).
Aggressive identical pricing on both molecules, wrapped in a coaching-first program.
Low-ish both-molecule pricing ($117/$196), nationwide — but unverified.
Mid-value both-molecule pricing ($135/$199), nationwide, though not verified.
Mass-market app-first program with nationwide reach and consumer-grade polish.
Both molecules across 40 states, but upper-mid pricing and no verification listing.
A heavyweight platform with brand-name access — but opaque compounded pricing drags its score.
A flat-fee compounded pioneer — simple, but priced at the higher end of the board now.
Pricing/verification reflect Direct Meds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Direct Meds's site. Not medical advice; see our disclosure.